The stock of Synutra International, Inc. (NASDAQ:SYUT) is a huge mover today! About 1.29 million shares traded hands or 375.55% up from the average. Synutra International, Inc. (NASDAQ:SYUT) has declined 12.11% since April 18, 2016 and is downtrending. It has underperformed by 16.54% the S&P500.
The move comes after 8 months positive chart setup for the $307.29 million company. It was reported on Nov, 18 by Barchart.com. We have $10.55 PT which if reached, will make NASDAQ:SYUT worth $304.22 million more.
According to Zacks Investment Research, “SYNUTRA INTERNATIONAL is a US incorporated company that wholly owns and operates six subsidiaries in China, all engaged in different stages of production, distribution and sales of dairy based infant formulas and other nutritional products.”
Another recent and important Synutra International, Inc. (NASDAQ:SYUT) news was published by Prnewswire.com which published an article titled: “Synutra International, Inc. Commences Construction of New Drying Facility in …” on January 14, 2014.
SYUT Company Profile
Synutra International, Inc., incorporated on February 23, 2004, is an infant formula firm in China. The Firm is engaged in the production, distribution and sale of dairy nutritional products under the Shengyuan or Synutra line of brands in the People’s Republic of China (PRC). The Company’s divisions include Nutritional Food, Nutritional Supplement and Other Business. It is focused on selling powdered formula products for infants and adults, and also engages in other nutritional product offerings, such as prepared foods and certain nutritional supplements. It sells most of its products through a nationwide sales and distribution network covering all provinces and provincial-level municipalities in mainland China. As of March 31, 2016, this network comprised over 850 independent distributors and over 290 independent sub-distributors selling its products in approximately 24,000 retail outlets.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.